Nalaganje...
Efficacy and Safety of Celecoxib in Chinese Patients with Ankylosing Spondylitis: A 6-Week Randomized, Double-Blinded Study with 6-Week Open-Label Extension Treatment
BACKGROUND: Nonsteroidal anti-inflammatory drugs are the first-line option for treating ankylosing spondylitis (AS) in China. However, no large-scale controlled trials have been conducted in this ethnic population. OBJECTIVE: To evaluate the efficacy and safety of 6 weeks’ treatment with celecoxib i...
Shranjeno v:
| izdano v: | Curr Ther Res Clin Exp |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2014
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4266770/ https://ncbi.nlm.nih.gov/pubmed/25516774 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.curtheres.2014.08.002 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|